ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch

Today's Daily Dose brings you news about Arena Pharma's OASIS trial results; national reimbursement of Abbott's MitraClip in Japan; Apellis Pharma's upcoming clinical trial catalysts; aTyr Pharma's near-term catalyst; PDUFA date for Pfizer's Xtandi sNDA, and Pain Therapeutics' regulatory catalyst in June.

from RTT - Biotech http://ift.tt/2G4BmLR
via IFTTT